Marshall Wace LLP Has $4.29 Million Stock Position in Perrigo Company plc (NYSE:PRGO)

Marshall Wace LLP raised its position in shares of Perrigo Company plc (NYSE:PRGO - Free Report) by 500.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 166,863 shares of the company's stock after acquiring an additional 139,080 shares during the period. Marshall Wace LLP owned approximately 0.12% of Perrigo worth $4,290,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Franklin Resources Inc. acquired a new stake in Perrigo in the 3rd quarter valued at approximately $3,717,000. Barclays PLC grew its stake in shares of Perrigo by 44.8% in the third quarter. Barclays PLC now owns 120,502 shares of the company's stock worth $3,160,000 after acquiring an additional 37,268 shares during the last quarter. JPMorgan Chase & Co. increased its position in Perrigo by 65.1% during the third quarter. JPMorgan Chase & Co. now owns 541,000 shares of the company's stock worth $14,190,000 after acquiring an additional 213,221 shares during the period. Virtu Financial LLC acquired a new position in Perrigo during the 3rd quarter valued at $909,000. Finally, Access Investment Management LLC bought a new stake in Perrigo in the 4th quarter valued at $7,989,000. 95.91% of the stock is owned by institutional investors and hedge funds.

Perrigo Price Performance

Shares of NYSE PRGO traded up $0.12 during midday trading on Wednesday, reaching $25.74. 1,346,961 shares of the company traded hands, compared to its average volume of 1,527,232. The firm has a market cap of $3.51 billion, a PE ratio of -22.00 and a beta of 0.49. The company has a debt-to-equity ratio of 0.94, a quick ratio of 1.77 and a current ratio of 2.56. The stock's 50-day simple moving average is $26.55 and its 200-day simple moving average is $26.07. Perrigo Company plc has a 12 month low of $23.14 and a 12 month high of $33.46.

Perrigo (NYSE:PRGO - Get Free Report) last announced its earnings results on Thursday, February 27th. The company reported $0.93 EPS for the quarter, topping the consensus estimate of $0.92 by $0.01. Perrigo had a positive return on equity of 7.38% and a negative net margin of 3.64%. The business had revenue of $1.14 billion for the quarter, compared to the consensus estimate of $1.20 billion. As a group, equities analysts anticipate that Perrigo Company plc will post 2.56 earnings per share for the current fiscal year.

Perrigo Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 17th. Shareholders of record on Friday, May 30th will be issued a dividend of $0.29 per share. This represents a $1.16 annualized dividend and a yield of 4.51%. Perrigo's dividend payout ratio is -92.80%.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on PRGO shares. StockNews.com cut shares of Perrigo from a "buy" rating to a "hold" rating in a research note on Wednesday, February 19th. Piper Sandler downgraded Perrigo from an "overweight" rating to a "neutral" rating and reduced their price objective for the stock from $34.00 to $27.00 in a research report on Monday, January 6th. Finally, Argus lowered Perrigo from a "buy" rating to a "hold" rating in a research note on Tuesday, January 14th. Four investment analysts have rated the stock with a hold rating and one has issued a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus target price of $33.00.

Insider Buying and Selling at Perrigo

In related news, EVP Ronald Craig Janish sold 7,800 shares of Perrigo stock in a transaction dated Monday, March 10th. The stock was sold at an average price of $27.44, for a total value of $214,032.00. Following the completion of the sale, the executive vice president now directly owns 33,666 shares in the company, valued at $923,795.04. This trade represents a 18.81 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 0.70% of the company's stock.

Perrigo Profile

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.